Apr
28

Coventry Q1 2006 earnings report

Coventry continues to deliver strong financial results across the board, with medical trend rates appearing to stabilize at about 8% and premium increases for Q1 somewhat above that rate. Overall membership growth is projected to be in the 1% – 3% range, with new employer customers are buying less-rich benefit plans and members at existing employer customers are shifting to less-rich plans (if multiple plan options are offered).
Part D sales efforts have been succesful, with 529,000 members enrolled to date, $180 million in revenue and margins somewhat better than expected. The growth was in part due to Coventry’s partnership with Medicare Supplement insurers, using the insurers as a distribution channel. Part of the $180 million was $50 million from CMS risk share payments.
The First Health business is producing the desired results although there has been strong pressure on the commercial plan part of FH. Revenues on the workers comp side were $51,425 million for the quarter, down slightly from the previous quarter’s $52,953 million. This is not unusual in the WC network and bill review business, as it tends to be somewhat cyclical.
Of note, Coventry Chairman Dale Wolf had previously suggested FH’s workers comp business would produce a $240 million top line in 2006. Given results to date, increasing price pressure on workers comp networks and bill review entities, and the growing likelihood that First Health will lose workers comp network business, I’d be surprised if FH produces anywhere close to $240 million in revenue.
Their failure to name a leader for the WC sector is not helping.
There were several questions about medical costs, trend rates, and drivers thereof. Uinlike other health plans, Coventry seems to be convinced that trend rates will not decrease, and will remain in the 8% range. When pressed to describe the positives and negatives, Coventry execs said that pharmacy is easier to address than in 2005 due to shift to generics, and biotech injectables continue to be problematic. On the big drivers, they see no big challenges with hospitals and physicians.


Apr
26

Workers comp rates: hard? soft? just right?

Well, are workers comp rates softening, hardening, or just right?
According to a study released at this year’s annual RIMS conference (held in Honolulu…), the market is softening. I’m not sure I buy that, and here’s why.
There are lots of moving pieces here that all have an impact on insurance rates: prior year losses; medical cost trend rates; expectations of losses for the coming policy year; claims volume projections; claim cost projections; equity market investment returns; interest rates; the amount of free capital in the market; etc.
So, one would need a supercomputer or really good ouija board to consider all these factors. Lacking either, I’ll use the trusty educated guess to prognosticate on the future of rates…
Workers comp rates are down about 3% over prior year renewals. This is due to more favorable investment returns (equity markets are up as are interest rates); a significant improvement in loss ratios in California (home to about 17% of the nation’s WC exposure); an expectation that reforms in Texas will significantly reduce costs in that key state; concern about potential claims for property and liability from past and future hurricanes (soaking up capital that could be used to write WC) and perhaps most significant, the continuing decline in claims frequency.
All these factors make for a relatively rosy outlook for comp. In fact, coupling the legislative and regulatory changes with the decline in claims frequency, one could argue that rates should be substantially lower than they are today.


Apr
24

Texas Mutual’s network is operational

Work Comp insurer Texas Mutual has launched their network initiative, partnering with Concentra on their private-labeled “Texas Star Network Option”. For now, the network will only be available to employers in the Austin, San Antonio, DFW and Houston metro areas, but expectations are the coverage area will expand significantly in the near future.
Texas Mutual has prepared excellent powerpoint presentations for employers employees and agents; anyone interested in an overview of the impact of the new legislation and regulatory changes would be well-served to review the presentations.
While Concentra’s network includes thousands of providers in Texas, Texas Mutual claims to have selected only certain providers for the Texas Star Network. One hopes this is the case, as the best feature of many workers comp networks is their ability to exclude docs who don’t get workers comp.


Apr
19

Fiserv’s focus on work comp pharmacy

The workers comp drug management landscape is getting even more complicated, with new entities and renamed ones entering the space seemingly every day. One of the latest to hit the radar is Innoviant, a subsidiary of Fiserv.
Remember Fiserv owns Third Party Solutions as well as DirectCompRx, a third party biller and PBM respectively.
It appears that an Innoviant unit that specializes in marketing to injured workers and their attorneys, telling them that Innoviant will eliminate out of pocket costs and hassles, delivering drugs quickly via mail order etc. Sources on the payer side indicate that Innoviant then bills at rates above what is usually deemed appropriate, claiming that their requested reimbursement levels are reasonable.
Moreover, one payer in Florida has seen a recent and rather large influx of bills from the Innoviant mail order folks; this payer is concerned that TPS bills are finding themselves inserted into the “mail order” category, thereby circumventing existing processes for capturing these scripts and redirecting to network pharmacies.
Innoviant also goes so far as to recommend attorneys to those injured workers who are in need of a little legal assistance. One wonders if there is a quid pro quo here…
So, Fiserv owns a third party biller, PBM, and home delivery company (marketed to physicians and attorneys); it does appear that they are seeking to serve all masters, even competing ones.


Apr
18

Ambulatory surgery centers – the financial black hole

Colleague and friend Peter Rousmaniere has an excellent column in the latest Risk and Insurance detailing some of the issues with Ambulatory Surgery Centers. To net it out, while they can get patients in quickly, are usually much nicer (in appearance) than hospitals, and can have equivalent outcomes, they are also wicked expensive (that’s my New England accent) , especially in states without an ASC fee schedule.
As a result, payers are increasingly looking to outside expert firms to assist in determining an appropriate reimbursement level. One that is especially adept in this area is Fair Pay Solutions (also an HSA client).


Apr
18

Not disability but ability

An article in today’s Baltimore Business Journal highlights a study by the American College of Occupational and Environmental Medicine on the impact of disability on employers’ bottom lines.
It will come as no surprise to industry experts that disability costs a ton of money, both hard dollars and soft, for insurance premiums, wage replacement, medical expenses, replacement workers and lost productivity. And, while it is good to see ACOEM publicizing the real costs of disability, this is not something that has not been addressed by many employers and experts in the past.
Jennifer Christian, MD, is the most articulate and insightful expert on the role of the physician in disability management. Tom Lynch of Lynch Ryan is the industry’s leading expert on safety and return to work planning. There are any number of physicians in private practice who focus deeply on return to work – Jorge Trujillo and Yemi Owi are two occupational medicine physicians who focus on what the patient can do, rather than what they can’t, and as a result have a stellar record in this area. Choice Medical Management has proven that sending injured workers to the right docs can dramatically improve return to work results.
And I’ve argued till blue in the face that any group health payer that wants to really differentiate in the market can do so by demonstrating their impact on absenteeism and productivity. Here’s hoping that a nascent initiative to do just that (evaluating a large HMO’s impact on a large University) gets things rolling (I’m involved as the chief nag to keep things moving along).


Apr
14

WorkingRx’s WCF strategy

WorkingRx’s suit against the Workers Comp Fund of Utah will likely shed some light on Working’s billing practices, methodology, and legal strategy. Working is a third party biller; a company that buys WC scripts from retail pharmacies and tries to get insurers to pay for them.
While that’s fine, and is a time-honored business practice in many retail and other industries with large receiveables, Working’s approach tends to be a bit more combative.
Working submits bills for reimbursement after applying their version of usual and customary, and then demands payment. Sources indicate that the WCF’s position is they have paid for the scripts already, and that Working’s demands are unreasonable. If Working’s other legal and collection actions are any indication, WCF may have a good point.
The issue is this; Working gets the bill from the retail pharmacy, and then reprices it using their own “usual and customary” methodology and/or adds an administrative fee. This last was shot down pretty abruptly in the WorkingRx-ScripNet legal battle, and WorkingRx’s U&C methodology is, well, unique.
One of the factors driving WorkingRx’s aggressive posturing and actions may well be the incentives of their legal team. Sources indicate that Working’s legal folk are, at least in part, financially rewarded for success in getting payers to cough up additional payments.


Apr
10

Troubles at IntraCorp

Industry sources indicate that managed care company IntraCorp is having its problems of late. It’s bill review business has declined rather drastically, with Sedgwick and ESIS both moving their work to other vendors. These two payers likely represent over 2 million bills annually, which may amount to 40% of IntraCorp’s business.
Organizationally, IntraCorp has been required to move into shared space, and is also using CIGNA corporate counsel and other G&A resources. This is a departure from the previously jealously-guarded independence enjoyed by IntraCorp.
IntraCorp’s new disability management chief, Archie Anderson, is a well-respected sales executive with a long history in the industry. It is most likely that these losses were well in the works before his arrival from Genex. It is likely that one of Archie’s challenges will be to generate enough case volume for Intracorp’s 2400 nurses. While the company continues to lead the industry in terms of sheer volume of cases managed, given the recent trend to reduce the role of field case management Intracorp may find itself with more nurses than it needs.
Unlike Concentra and First Health, Intracorp does not have a large cash-generating PPO network to drive profits. However, with the recent decline in popularity of these big discount-driven networks, this may not be too problematic. If Intracorp can develop or acquire technology that enables it to truly integrate and manage specialty managed care services on a custom basis, it may be able to leapfrog the competition.
That’s a big “if”.


Apr
7

Is flu a workers comp illness?

California HealthLine picked up a story from the journal Science on transmission of the flu. Turns out that business travelers are a key vector in the spread of the disease around the US.
As one who spends way too much time on planes trains and waiting around for same, I guess I’m an occasional carrier as well. Sorry.
So here’s the interesting question – aren’t those traveling on business who return home with the aches pains and other nasty effects of the flu covered under workers comp? Their travel is business-related, and if they are in an accident that’s a comp claim, so…?


Apr
6

Survey of Prescription Drug Management in Workers Comp

My firm, Health Strategy Associates, is conducting the Third Annual Survey of Prescription Drug Management in Workers Comp, and I’m hoping to have the final report completed before the end of April. Here are a couple of interesting bits that have come up in the 20+ interviews conducted to date.
1. There is a rather striking difference in the pharmacy inflation rate between what I would characterize as less- and more-sophisticated payers. Some payers have held their inflation rates down in the lower single digits, others are seeing trend rates above 15%.
2. Claim frequency decreases get part of the credit for low pharmacy inflation, but not all of it.
3. The number of PBMs is growing, but no PBM has a dominant market position. In fact, many senior execs don’t know much about the PBMs beyond their names.
4. Cost inflation tends to be attributed to more “designer” drugs, e.g. more expensive branded drugs being prescribed when a cheaper generic would likely work; direct to consumer advertising’s impact on consumers, and more claimants getting more drugs for longer periods.
5. This last is probably the most consistent thread running throughout the interviews – a heightened awareness of and concern about the sheer volume of drugs prescribed.
I’ll post additional highlights when they make themselves apparent. If you want a copy of the survey report, email me at jpaduda@healthstrategyassoc.com.